Bioventus Inc. Class A Common Stock

BVSNASDAQUSD
9.04 USD
0.34 (3.91%)AT CLOSE (11:59 AM EDT)
8.98
0.06 (0.71%)
POST MARKET (AS OF 05:53 PM EDT)
Post Market
AS OF 05:53 PM EDT
8.98
0.06 (0.71%)
🔴Market: CLOSED
Open?$8.85
High?$9.21
Low?$8.81
Prev. Close?$8.70
Volume?698.4K
Avg. Volume?631.4K
VWAP?$9.09
Rel. Volume?1.11x
Bid / Ask
Bid?$7.76 × 100
Ask?$10.33 × 100
Spread?$2.57
Midpoint?$9.05
Valuation & Ratios
Market Cap?589.4M
Shares Out?67.7M
Float?38.8M
Float %?58.0%
P/E Ratio?20.69
P/B Ratio?3.12
EPS?$0.42
Dividend?0.00%
Ex-Dividend?N/A

BVS is currently priced at $9.03. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone and a bullish Golden Cross on the moving averages. On the valuation side, BVS appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Employees
940
Market Cap
589.4M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-02-11
Address
4721 EMPEROR BOULEVARD, SUITE 100
DURHAM, NC 27703
Phone: (919) 474-6700
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
21
Momentum?
50
Short Sent.?
70
Piotroski F-Score?6/9Mixed
Altman Z-Score?1.50Distress
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.06%Low
Short Interest?1.6M
Days to Cover?2.9
Free Float38.8M
Avg Daily Volume537.9K
Settlement Date2026-05-15
Financial Health
Current Ratio?1.69Adequate
Quick Ratio?1.13Adequate
Cash Ratio?0.24Low
Debt/Equity?1.44Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
89/100
P/E?
Peers
100
S&P
63
20.7FAIR
P/B?
Peers
100
S&P
54
3.12FAIR
P/S?
Peers
100
S&P
86
1.02CHEAP
P/FCF?
Peers
100
S&P
97
5.9CHEAP
EV/EBITDA?
Peers
100
S&P
92
7.8CHEAP
EV/Sales?
Peers
100
S&P
85
1.43CHEAP
Returns & Efficiency
ROE?
Peers
50
S&P
54
15.1%STRONG
ROA?
Peers
50
S&P
40
4.4%FAIR
Cash Flow & Enterprise
FCF?$100.6M
Enterprise Value?$825.6M
Fundamentals ratios updated end of day